Date: 2024/11/03 - 00:50
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect the heart. However, certain doses and delivery systems can lead to side effects affecting the gut.
The risk of developing type 2 diabetes, stroke, and depression may be higher in people with a "sweet tooth" who prefer sugary foods, new research suggests.
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows.
People who maintain or start physical activity of any intensity after receiving a dementia diagnosis may be at a decreased risk for all-cause mortality, a new study suggests.
Date: 2024/10/30 - 18:24
NIH study suggests potential for earlier health interventions for people with West African ancestry.
Date: 2024/10/19 - 19:40
Increased risk among men in disadvantaged neighborhoods may be linked to chronic stress.
Plan will advance knowledge of virus biology to improve detection, treatment and prevention.
Network will analyze and improve how genomic information is integrated into patient care.
Date: 2024/10/19 - 01:25
Effort to identify risk factors for youth-onset type 2 diabetes to improve prevention and treatment.
NIH clinical trial addresses knowledge gap on vaccine use in adolescent populations